Cepharanthine hydrochloride inhibits prostate cancer progression by modulating gut microbiota and metabolites

This study is the first to explore the potential mechanisms of gut microbiota-mediated CH treatment for prostate cancer, providing a scientific basis for the application of CH in PCa therapy.